EcoDrugPlus

Tubulin Alpha 4a

Ensembl ID : ENSPSNG00000018656
Gene Symbol: TUBA4A
3 Cross references
224 Possible Orthologues:

Tubulin Beta 1 Class Vi

Ensembl ID : ENSPSNG00000016273
Gene Symbol: TUBB1
3 Cross references
186 Possible Orthologues:

Tubulin Beta 2a Class Iia

Ensembl ID : ENSPSNG00000015438
Gene Symbol: TUBB2A
3 Cross references
183 Possible Orthologues:

Tubulin Beta 3 Class Iii

Ensembl ID : ENSPSNG00000009538
Gene Symbol: TUBB3
1 Cross references
144 Possible Orthologues:

Tubulin Beta 4a Class Iva

Ensembl ID : ENSPSNG00000005996
Gene Symbol: TUBB4A
3 Cross references
94 Possible Orthologues:

Tubulin Beta 6 Class V

Ensembl ID : ENSPSNG00000020945
Gene Symbol: TUBB6
3 Cross references
141 Possible Orthologues:

Tubulin Beta Class I

Ensembl ID : ENSPSNG00000012487
Gene Symbol: TUBB
3 Cross references
23 Possible Orthologues:

Tumor Protein P53

Ensembl ID : ENSPSNG00000009871
Gene Symbol: TP53
3 Cross references
253 Possible Orthologues:

Tyrosinase

Ensembl ID : ENSPSNG00000016603
Gene Symbol: TYR
1 Cross references
266 Possible Orthologues:

Tyrosine Hydroxylase

Ensembl ID : ENSPSNG00000004465
Gene Symbol: TH
3 Cross references
187 Possible Orthologues:

Tyrosine Kinase 2

Ensembl ID : ENSPSNG00000020692
Gene Symbol: TYK2
3 Cross references
196 Possible Orthologues:

Tyrosine Kinase With Immunoglobulin Like And Egf Like Domains 1

Ensembl ID : ENSPSNG00000002270
Gene Symbol: TIE1
3 Cross references
203 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects from the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects from the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).